Suppr超能文献

吸入性糖皮质激素在儿童哮喘中的应用。

The use of inhaled corticosteroids in childhood asthma.

出版信息

Drug Ther Bull. 1999 Oct;37(10):73-7. doi: 10.1136/dtb.1999.371073.

Abstract

In the UK around 1 in 5 children will have been diagnosed as having asthma at some stage before they reach 15 years old. The use of inhaled corticosteroids has done much to reduce morbidity in these children and current British Guidelines recommend the use of inhaled corticosteroids in all but mild childhood asthma. However, there are concerns about the long-term safety of such treatment in growing children, and the benefits and risks of their use need careful evaluation. In this article we review the place of inhaled corticosteroids in childhood asthma.

摘要

在英国,约五分之一的儿童在15岁之前的某个阶段会被诊断出患有哮喘。吸入性糖皮质激素的使用在很大程度上降低了这些儿童的发病率,目前英国的指南建议,除轻度儿童哮喘外,所有儿童哮喘均应使用吸入性糖皮质激素。然而,人们担心这种治疗方法对正在成长的儿童的长期安全性,其使用的益处和风险需要仔细评估。在本文中,我们将综述吸入性糖皮质激素在儿童哮喘治疗中的地位。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验